Business Context and Reporting Period
This Form 6-K filing by UBS Group AG, dated August 14, 2024, provides consolidated capitalization data as of June 30, 2024. The financial statements are prepared in accordance with IFRS Accounting Standards and presented in US dollars. This report supplements the annual Form 20-F and quarterly Form 6-K filings, incorporating disclosures related to the acquisition of Credit Suisse Group.
Key Financial Metrics
The filing focuses on capitalization structure rather than operational performance metrics like revenue or profit.
| Capitalization Item (USD millions) | As of June 30, 2024 | As of March 31, 2024 |
|---|---|---|
| Short-term debt issued | 92,826 | 96,331 |
| Long-term debt issued | 249,607 | 246,726 |
| Total debt issued | 342,432 | 343,056 |
| Equity attributable to shareholders | 83,683 | 84,777 |
| Equity attributable to non-controlling interests | 535 | 506 |
| Total capitalization | 426,650 | 428,339 |
Debt Composition: As of June 30, 2024, 89% of total debt issued was unsecured. Long-term debt includes instruments eligible as high-trigger loss-absorbing additional tier 1 capital ($12,400 million), low-trigger loss-absorbing additional tier 1 capital ($1,225 million), and non-Basel III-compliant tier 2 capital ($536 million).
Material Changes
- Total Debt: Decreased slightly by $624 million from $343,056 million to $342,432 million.
- Short-term Debt: Decreased by $3,505 million.
- Long-term Debt: Increased by $2,881 million.
- Shareholder Equity: Decreased by $1,094 million to $83,683 million.
- Total Capitalization: Decreased by $1,689 million to $426,650 million.
Comparative-period information for March 31, 2024, has been revised in accordance with Note 2 regarding the accounting for the acquisition of Credit Suisse Group.
Guidance, Outlook, and Risks
This specific filing does not contain management commentary, forward-looking guidance, or a discussion of risks and contingencies. It serves primarily as a disclosure of capitalization figures required for incorporation by reference into registration statements (Forms F-3 and S-8). Investors are directed to the full second quarter 2024 report for detailed risk factors and outlook.
Investor Verification Checklist
- Verify the impact of the Credit Suisse acquisition accounting revisions on comparative equity figures.
- Confirm the composition of long-term debt eligible for regulatory capital treatment (AT1 and Tier 2).
- Review the full Q2 2024 report for revenue, profit, and cash flow data not included in this capitalization summary.
- Assess the liquidity position given the reduction in short-term debt and total capitalization.